Head-to-head · Cost-Efficiency Index
Intimate Rose vs Freya Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Intimate Rose
Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers.
Visit Intimate RoseFreya Meds
Shoppers who want a GLP-1-only telehealth bundle with dietitian and group-call access included, and are willing to compare the quarterly vs. monthly rate.
Visit Freya MedsThe verdict
Intimate Rose and Freya Meds tie on the Cost-Efficiency Index at 53/100, so neither wins outright on the numbers. For most shoppers we'd start with Intimate Rose (ranked #368, a hair above #372) — Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers. But Freya Meds is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Intimate Rose.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Intimate Rose | Freya Meds |
|---|---|---|
| Cost-Efficiency Index | 53/100 | 53/100 |
| Semaglutide / mo | $169/mo (starting dose, compounded) | $297/mo (0.20 mg dose, compounded) |
| Tirzepatide / mo | Not disclosed | $390/mo (0.20 mg dose, compounded) |
| Semaglutide / yr (modeled) | $2,028 | $3,564 |
| Tirzepatide / yr (modeled) | — | $4,680 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #368 | #372 |
Intimate Rose
53/100Where the value is
- A real, working GLP-1 telehealth funnel exists (not a dead link or vaporware page)
- The quiz states 'No payment to get started', so shoppers can get a personalized quote before committing
- Backed by an established, non-fly-by-night e-commerce brand with an existing customer base and content library
The tradeoffs
- GLP-1 is a secondary bolt-on to a pelvic-health device business, not this company's core competency — no dedicated GLP-1 clinical infrastructure is visible on the public site
- Only one undifferentiated price point ($169/month) is published — no dose tiers, no separate semaglutide vs. tirzepatide pricing, no fee itemization
Regulatory note: the FDA issued a warning letter to Intimate Rose in September 2025. We still list and link to Intimate Rose; you should know the letter is on the public record before you decide.
Freya Meds
53/100Where the value is
- GLP-1 specialist, not a multi-category telehealth platform
- Both quarterly ($250/$332) and monthly ($297/$390) rates are transparently published on the product pages themselves, cancel-anytime with no lock-in
- Bundle includes unlimited doctor consultations, monthly group calls, and a dietitian consultation at no extra charge
The tradeoffs
- The homepage's headline '$150/mo' and '$249/mo' figures do not match either selectable plan on the actual product pages ($250-$390/mo) — they appear to be an annual-prepay rate surfaced by a customer testimonial rather than a plan a shopper can actually select on the pages checked
- No LegitScript certification or equivalent third-party accreditation found on any page checked
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.